5 | LEGE 41% v2,2M c.0271 f112M H | znewcar1 | 10/04/2019 4:17:02 PM |
4 | LEGE 46% v1,8M c.0278 f112M morning pop D.035 the | znewcar1 | 09/20/2019 4:04:31 PM |
3 | 71.45% v1,419,200 c.017145 f112,813,355 morning | znewcar1 | 02/11/2019 6:22:15 PM |
2 | LEGE 0.0053 Stock Charts $LEGE 1 Month Chart | chartguy89 | 03/08/2014 5:44:11 AM |
1 | LEGE Stock Charts Last: UNCH Thursday, February | chartguy89 | 02/27/2014 1:05:39 PM |
Recent Articles
- Lip-Bu Tan Takes the Helm at Intel: A New Era Begins
- Exploring the Rising Trends in the Cloud MES Market Growth
- Strategic Progress for Jeffs' Brands Amid Planned Merger
- VITAS Healthcare's Dr. Sandhya Bhalla Recognized as Fellow
- ZenaTech Boosts Workforce to Meet Growing Drone Production Demand
- Creative Realities, Inc.'s 2024 Earnings Call and Insights
- Quoin Pharmaceuticals' Remarkable Growth in 2024 Highlights
- Amy Gilliland Joins Rett Syndrome Research Trust's Board
- Knight Therapeutics to Discuss Year-End Results for 2024
- Dragonfly Energy to Share Key Financial Results Soon
- Creative Realities, Inc. Unveils Upcoming Earnings Call Details
- Indaptus Therapeutics Shows Promising Trial Progress and Growth
- Knight Therapeutics to Discuss 2024 Financial Results on Call
- MeiraGTx Partners with Hologen AI for Advancing Parkinson's Treatment
- Tourmaline Bio's Promising Developments in Clinical Trials
- PDD Holdings Prepares to Reveal Q4 and Annual Results
- MeiraGTx Speeding Phase 3 Development with Hologen AI Partnership
- Michael Herde Joins FTI Consulting to Transform Financial Services
- Trinity Biotech Expands Strategic Focus on CGM Technology
- Dragonfly Energy Unveils Upcoming Q4 2024 Financial Results
- MIRA Pharmaceuticals Unveils New Topical Treatment for Pain Relief
- PDD Holdings Set to Announce Fourth Quarter Financial Results
- FTI Consulting Welcomes New Senior Managing Director
- Verde Resources Revolutionizes Road Construction with Tech
- Altisource Reports Impressive Fourth Quarter and Yearly Gains
- Quoin Pharmaceuticals Achieves Key Milestones While Reporting 2024 Results
- Advanced Flower Capital Inc. Reveals 2024 Year-End Financials
- Tourmaline Bio Unveils Promising Financial Results and Highlights
- Understanding Alliance Witan PLC’s Net Asset Value Adjustments
- Indaptus Therapeutics: Significant Milestones and Future Prospects
- Ballard Power Systems Reports Challenging Q4 Results
- AMSURG's New Values Enhance Patient-Centric Culture
- Altisource Surpasses Revenue Expectations in 2024
- Gentoo Media Shareholders Decide on Euronext Delisting Move
- Danaos Corporation's 2024 Annual Report Now Available for Review
- Advanced Flower Capital Reports 2024 Year-End Financials
- India Giving Day: A Call to Action for Philanthropy Growth
- Virax Biolabs Unveils Findings on T-Cell Dysfunction at Conference
- Phoenix Financial Reports Strong 2024 Financial Results
- Stratus Building Solutions: Celebrating Franchise Growth Success
- DocuSign Sees Positive Analyst Ratings Ahead of Q4 Results
- Transform Your Photos with Mango AI's Innovative Tool
- The Cigna Group's Strategic Leadership Changes for Growth
- Ballard Power Systems' Q4 2024 Financial Overview and Outlook
- PSP Investments Expands Portfolio with 407 ETR Acquisition
- Dalai Lama Receives Gold Mercury Award for Peace Initiatives
- LEAD3R Introduces Innovative Workshop for Inclusive Leadership
- Phoenix Financial Unveils Strong Performance and Growth Plans
- Lucid Diagnostics Achieves Milestone with Insurance Coverage
- Onity Group's Upcoming Presentation at Major Investor Conference